Q1 2025 Holdings
Filed 2025-05-15 | 66 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $363.2K | 240,513 | 0.0% |
| Turnstone Biologics Corp | COM | 90042W100 | $382.3K | 932,348 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $440.1K | 132,152 | 0.0% |
| Celcuity Inc(CELC) | COM | 15102K100 | $539.4K | 53,349 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $699.3K | 40,400 | 0.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $710.6K | 155,495 | 0.1% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $1.0M | 15,488 | 0.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.1M | 104,323 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.2M | 26,437 | 0.1% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $1.2M | 885,803 | 0.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $1.3M | 451,267 | 0.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $1.3M | 140,681 | 0.1% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $2.1M | 649,006 | 0.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.3M | 2,506,435 | 0.2% |
| Werewolf Therapeutics Inc(HOWL) | COM | 95075A107 | $2.4M | 2,506,520 | 0.2% |
| Spdr SER TR(XRT) | S&P RETAIL ETF | 78464A714 | $2.5M | 36,471 | 0.2% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $2.6M | 2,341,107 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.0M | 834,135 | 0.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.1M | 92,236 | 0.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.2M | 50,809 | 0.2% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.6M | 3,301,942 | 0.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $4.1M | 46,453 | 0.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $4.7M | 197,307 | 0.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $4.8M | 3,489,559 | 0.3% |
| Neogenomics Inc(NEO) | COM NEW | 64049M209 | $5.6M | 585,381 | 0.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $6.1M | 160,866 | 0.4% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $6.1M | 439,283 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.4M | 599,967 | 0.5% |
| Icon PLC(ICLR) | SHS | G4705A100 | $7.2M | 41,038 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $8.2M | 570,546 | 0.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $8.2M | 135,398 | 0.6% |
| Sarepta Therapeutics Inc | NOTE 1.250% 9/1 | 803607AD2 | $9.3M | $10,000,000 | 0.7% |
| Spdr SER TR(XRT)Call | S&P RETAIL ETF | 78464A714 | $10.9M | 157,200 | 0.8% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $10.9M | 21,897 | 0.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.0M | 150,200 | 0.8% |
| Indivior PLC(INDV) | ORD | G4766E116 | $11.1M | 1,159,833 | 0.8% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $11.3M | 860,821 | 0.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $11.4M | 926,424 | 0.8% |
| Humana Inc(HUM) | COM | 444859102 | $16.7M | 63,238 | 1.2% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $18.6M | 1,685,727 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $18.8M | 35,904 | 1.4% |
| Waters Corp(WAT) | COM | 941848103 | $19.1M | 51,858 | 1.4% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $19.7M | 111,854 | 1.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $21.0M | 91,571 | 1.5% |
| CVS Health Corp(CVS) | COM | 126650100 | $21.2M | 312,305 | 1.5% |
| Danaher Corporation(DHR) | COM | 235851102 | $23.1M | 112,475 | 1.7% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $23.1M | 70,088 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.5M | 87,145 | 1.7% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $26.8M | 77,464 | 1.9% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $27.3M | $23,000,000 | 2.0% |